OnKure Therapeutics (OKUR) Interest Coverage Ratio (2024 - 2025)
OnKure Therapeutics' (OKUR) quarterly Interest Coverage Ratio came in at 2354.17 in Q4 2025, down 617.62% on a YoY basis from 454.81 in Q4 2024, and up 69.63% quarter-over-quarter from 7750.5 in Q3 2025.
Powered by 
Analysis
OnKure Therapeutics (OKUR) Interest Coverage Ratio (2024 - 2025) Analysis & Trends
OnKure Therapeutics (OKUR) has reported Interest Coverage Ratio for 2 consecutive years, with 2354.17 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio fell 617.62% year-over-year to 2354.17; the trailing twelve-month figure through Dec 2025 stood at 222.44 (changed N/A YoY), and the FY2025 full-year result was 7868.75, down 4240.5% from the prior year.
- Interest Coverage Ratio advanced to 2354.17 in Q4 2025 per OKUR's latest filing, from 7750.5 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 52.81 in Q3 2024 and bottomed at 7750.5 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | OnKure Therapeutics | 162.57 Mn | -13.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -2,354.17 |
| Sep 30, 2025 | -7,750.50 |
| Dec 31, 2024 | -328.05 |
| Sep 30, 2024 | -52.81 |
| Jun 30, 2024 | -551.65 |